Trial
NCT03347617
Ferumoxytol MRI in Assessing Response to Pembrolizumab in Patients With Glioblastoma
Phase IITERMINATEDOTHER/UNKNOWNConfidence: LOW
Sponsor
OHSU Knight Cancer Institute
Collaborators
National Cancer Institute (NCI); Oregon Health and Science University
Condition
Glioblastoma
Intervention
Ferumoxytol
Why stopped
Principal investigator transition
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2025-09-09